Association of GLP-1 Receptor Agonist Prescriptions and Alcohol Consumption in the National Institutes of Health’s All of Us Cohort

Key Points

• Reduced alcohol consumption was linked to GLP-1 receptor agonist prescriptions in the study cohort.
• Frequent alcohol use decreased notably among individuals using GLP-1 receptor agonists.
• Observational analysis across the National Institutes of Health’s All of Us cohort identified trends in alcohol consumption.
• The findings highlight the need for randomized controlled trials to explore mechanisms and efficacy further.